Perceptions about oral isotretinoin treatment

Abstract

There are some studies on the knowledge, beliefs, and perceptions of patients about acne vulgaris, however, there is no sufficient data on patients' beliefs about oral isotretinoin treatment (OIT). The aim of this study was to assess the knowledge, beliefs, and perceptions of the patients with acne vulgaris about the therapy of OIT and its side effects. A total of 214 patients with acne vulgaris in our outpatient clinic were included. Patients who were planned to treat with OIT were asked whether they had information about the treatment and its side effects. It was noted whether the patients accepted treatment after being informed both verbally and written about the OIT details. The study consisted of 133 female and 81 male aged 12–57 years. Most of the patients (78%) stated that they had heard of OIT. The most common source of the information on isotretinoin therapy was friends (57.6%). The dryness was the best‐known side effect. While 86.4% of patients (n: 185) accepted OIT, the group (14.4%) stated that “I have knowledge about side effects.” And refused to use the treatment. Most of the patients agreed to the treatment after explanation of dermatologist. Patients may be educated and informed via reliable medical sources to prevent bias and improve compliance to the treatment.

Evaluation of 25‐hydroxy vitamin D levels and disease severity in patients with acne vulgaris

“…Acne vulgaris is a common, multifactorial, and complex skin disorder that affects the quality of social life in patients 6,9‐11 …”

Evaluation of oral isotretinoin effects on hearing system in patients with acne vulgaris: Reversible or not?

“…The teratogenic adverse effects of isotretinoin increases the risk of spontaneous abortion 8 . Even though it has several side effects on multiple systems, effects on the hearing system have rarely been reported 3,5,15,16 . In 1988, Bigby et al reported 104 suspected adverse reactions occurring in 93 patients who took isotretinoin, and they found decreased hearing in one patient who received the therapy and classified this as possibly related to isotretinoin use 3 .…”

Aspectos Epidemiológicos Da Leishmaniose Visceral No Estado Do Piauí No Período De 2015 a 2018

“…As indicações aprovadas são: acne nódulo-cística grave e pápulo-pustulosa moderada que não melhora com tratamentos convencionais em dois ou três ciclos, recidiva rápida, tendência a cicatrizes e impacto psicossocial negativo (Tugrul, 2019;Vallerand, 2018;Thiboutot, 2018;Landis, 2020). As doses recomendadas são: diária de 0,5 a 1,0 mg/kg, e total de 120 a 150 mg/kg.…”